Weight-Loss Diet Intervention on Cardiometabolic Factors of Gut Microbiota

$454,897R01FY2014DKNIH

Harvard School Of Public Health, Boston MA

Investigators

Linked publications & trials

Paper 39532828 Paper 39164879 Paper 38618988 Paper 38454415 Paper 38428740 Paper 38410999 Paper 38382419 Paper 38321471 Paper 38252435 Paper 38229469 Paper 38052941 Paper 37770056 Paper 37662961 Paper 37415079 Paper 37199161 Paper 37039021 Paper 37036905 Paper 36800272 Paper 36402008 Paper 35657082 Paper 35580715 Paper 35348584 Paper 35297116 Paper 35220441 Paper 35202470 Paper 35172255 Paper 35165382 Paper 35135690 Paper 35112774 Paper 34996567 Paper 34799774 Paper 34748263 Paper 34605583 Paper 34531019 Paper 34460827 Paper 34448488 Paper 34426648 Paper 34237797 Paper 34237696 Paper 34218856 Paper 34091070 Paper 33648986 Paper 33515005 Paper 33277814 Paper 33190528 Paper 33051670 Paper 32861332 Paper 32847829 Paper 32561903 Paper 32493715 Paper 32383070 Paper 32380520 Paper 32274554 Paper 31988063 Paper 31848595 Paper 31842690 Paper 31826236 Paper 31768000 Paper 31656094 Paper 31542245 Paper 31332027 Paper 31271198 Paper 31216010 Paper 31189526 Paper 31138550 Paper 31136655 Paper 31088786 Paper 30646822 Paper 30517623 Paper 29974585 Paper 29860242 Paper 29693310 Paper 29632104 Paper 29590381 Paper 29568104 Paper 29516223 Paper 29321156 Paper 29305401 Paper 29187356 Paper 29158491 Paper 29098321 Paper 29089366 Paper 28925411 Paper 28882871 Paper 28701334 Paper 28662937 Paper 28659346 Paper 28496128 Paper 28486942 Paper 28443625 Paper 28254173 Paper 28148682 Paper 28138133 Paper 27841942 Paper 27650503 Paper 27600066 Paper 27596972 Paper 27581055 Paper 27540264 Paper 27466884

Abstract

DESCRIPTION (provided by applicant): Gut microbiota has recently emerged as a novel, metabolically active 'organ', tightly linked to obesity and related metabolic disorders such as diabetes and cardiovascular disease; and compelling evidence indicates that several key metabolites (TMAO, L-carnitine, bile acids subtypes) related to gut microbiota metabolism may play pivotal roles in mediating the metabolic effects. Diet is a major force that shapes gut microbiota and weight loss may alter metabolism of gut microbiota. The goal of this application is to examine the long-term (2 years) effects of weight-loss diets varying in macronutrients (fat, protein, and carbohydrate) on the novel cardiometabolic metabolites involved in gut microbiota metabolism in 811 overweight or obese patients from thus far one of the largest and most comprehensive comparator trials on the popular weight-loss diets - the POUNDS LOST trial. We will also assess the relation of changes in plasma gut microbiota metabolites with changes in markers of energy intake and expenditure, including gut hormones (GLP-1, ghrelin), resting metabolic rate (RMR), and total energy expenditure (TEE) measured by doubly-labeled water (DLW); as well as with changes in metabolic risk factors including insulin sensitivity, lipids, adipokines, inflammation, and amino acids. In addition, we will examine the associations between gut microbiota metabolites and global adipose gene expression. Because measurement of energy balance and metabolic markers, and adipose gene expression are funded through separate grants, the proposed project will be conducted in an extremely cost-efficient manner. We have assembled a solid group of experienced collaborators with expertise in epidemiology, metabolomics, gene expression, statistics, clinical trial, and nutrition. We believe that findings of this project will provide novel insights into the metabolic effects of gut microbiota and their relations with dietary factors; and considerably contribute to advance toward new prevention and treatment strategies for obesity and related metabolic disorders through diet intervention.

View original record on NIH RePORTER →